Product Information
EBGLYSS 250 MG/2 ML PEN is a brand product labeled by Eli Lilly and Company, priced at $1784.3443 per ML under NDC 00002777211. Its NADAC has been published 36 times since Dec 17, 2025.
Strength
250 mg/2mL
Manufacturer
Eli Lilly and CompanyNDC
00002777211
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
LEBRIKIZUMABApproval Type
Biologic (BLA)
FDA Application
BLA761306On Market Since
9/13/2024
Pharmacological Classes
Price Statistics
The NADAC for EBGLYSS 250 MG/2 ML PEN has been published 36 times since Dec 17, 2025, and over the history we have for it it has risen 4.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1784.3443 per ML |
|---|---|
| All-time high | $1795.8056 (Jun 10, 2026) |
| All-time low | $1710.2910 (Dec 17, 2025) |
| 52-week high | $1795.8056 |
| 52-week low | $1710.2910 |
| Median price | $1795.8056 |
| Average price | $1783.4363 |
| Largest weekly change | +5.0% (Jan 14, 2026) |
| Weeks tracked | 36 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the lebrikizumab-lbkz market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EBGLYSS 250 MG/2 ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for EBGLYSS 250 MG/2 ML PEN, manufactured by Eli Lilly and Company, is $1784.3443 per ML (NDC 00002777211), effective Aug 19, 2026.
How has the price of EBGLYSS 250 MG/2 ML PEN changed over time?
Over the history we have for it, the NADAC for EBGLYSS 250 MG/2 ML PEN has risen 4.3%. It has been tracked across 36 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for EBGLYSS 250 MG/2 ML PEN?
Since Dec 17, 2025, the NADAC for EBGLYSS 250 MG/2 ML PEN has ranged from a low of $1710.2910 (Dec 17, 2025) to a high of $1795.8056 (Jun 10, 2026), with a median of $1795.8056 per ML.
Are there cheaper alternatives to EBGLYSS 250 MG/2 ML PEN?
No other NADAC-published product currently shares the active ingredient and strength of EBGLYSS 250 MG/2 ML PEN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures EBGLYSS 250 MG/2 ML PEN?
EBGLYSS 250 MG/2 ML PEN (NDC 00002777211) is labeled by Eli Lilly and Company, and CMS classifies it as a brand product.